Evidence map›Paper›PMID 33919709›Full record

ArticleMicromachines2021

Advances in Nanofluidics.

Yutaka Kazoe, Yan Xu

Abstract readEditorial
In one paragraph

Article in Micromachines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yutaka KazoeDepartment of System Design Engineering, Faculty of Science and Technology, Keio University, Yokohama 223-8522, Japan.ORCID 0000-0002-8334-6730
Yan XuDepartment of Chemical Engineering, Graduate School of Engineering, Osaka Prefecture University, Osaka 599-8570, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, a new frontier in fluid science and engineering at the 1 to 1000 nm scale, called nanofluidics, has developed and provided new methodologies and applications to the fields of chemistry, biology, material sciences, bioengineering, medicine, drug discovery, energy, and environmental engineering [...].

Identifiers

PMID33919709
PMCPMC8070681

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.